Search

Your search keyword '"M. Krieger"' showing total 84 results

Search Constraints

Start Over You searched for: Author "M. Krieger" Remove constraint Author: "M. Krieger" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
84 results on '"M. Krieger"'

Search Results

1. An environmental justice analysis of air pollution emissions in the United States from 1970 to 2010

2. Impact of probiotic Veillonella atypica FB0054 supplementation on anaerobic capacity and lactate

3. Corrigendum: A randomized controlled trial to examine the impact of a multi-strain probiotic on self-reported indicators of depression, anxiety, mood, and associated biomarkers

4. Estimating conformational landscapes from Cryo-EM particles by 3D Zernike polynomials

5. A randomized controlled trial to examine the impact of a multi-strain probiotic on self-reported indicators of depression, anxiety, mood, and associated biomarkers

6. Mechanisms underlying TARP modulation of the GluA1/2-γ8 AMPA receptor

7. Within-herd prevalence threshold for the detection of Mycobacterium avium ssp. paratuberculosis antibody–positive dairy herds using pooled milk samples: A field study

8. Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions

9. Sampling of Protein Conformational Space Using Hybrid Simulations: A Critical Assessment of Recent Methods

10. Impact of crystalline defects in 4H-SiC epitaxial layers on the electrical characteristics and blocking capability of SiC power devices

13. MP63-05 OUTCOMES IN PATIENTS (PTS) WITH BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE HIGH-RISK (HR) NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) WHO UNDERWENT RADICAL CYSTECTOMY (RC) FOLLOWING PEMBROLIZUMAB (PEMBRO) TREATMENT IN KEYNOTE-057 COHORT A

14. LBA03-08 PEMBROLIZUMAB (PEMBRO) FOR PATIENTS (PTS) WITH HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (HR NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG): EFFICACY AND EVALUATION OF SUBSEQUENT CYSTECTOMY FROM COHORT B OF THE PHASE 2 KEYNOTE-057 STUDY

15. Impact of Epitaxial Defects on Device Behavior and their Correlation to the Reverse Characteristics of SiC Devices

16. Retrospective evaluation of canine primary, multicentric, and metastatic intraocular neoplasia

17. Social Impact and Positive Change in Russia Opinions of six experts regarding the present and future of the impact approach in Russia

18. Decreased Serotonin Transporter Activity in the Mitral Valve Contributes to Progression of Degenerative Mitral Regurgitation

20. 3D range-modulators for proton therapy: near field simulations with FLUKA and comparison with film measurements

22. Probiotic BC30 Improves Amino Acid Absorption from Plant Protein Concentrate in Older Women

23. Dose-Response Absorption Kinetics of Oral L-Beta-Aminoisobutyric Acid (L-BAIBA) Supplementation in Healthy Men and Women

26. Demonstration of plasma mirror capability for the OMEGA Extended Performance laser system

27. Inhibition of advanced glycation end product formation and serum protein infiltration in bioprosthetic heart valve leaflets: Investigations of anti-glycation agents

28. Poly-2-methyl-2-oxazoline–modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration

29. The Hydrocephalus Clinical Research Network quality improvement initiative: the role of antibiotic-impregnated catheters and vancomycin wound irrigation

30. Development of a hardened THz energy meter for use on the kilojoule-scale, short-pulse OMEGA EP laser

32. Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette–Guérin (BCG): Results from cohort B of the phase 2 KEYNOTE-057 trial

33. Rucaparib for metastatic castration-resistant prostate cancer (mCRPC): TRITON3 interim overall survival and efficacy of rucaparib vs docetaxel or second-generation androgen pathway inhibitor therapy

34. Phase 2 clinical study evaluating the efficacy and safety of disitamab vedotin with or without pembrolizumab in patients with HER2-expressing urothelial carcinoma (RC48G001)

36. GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation

37. The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment

38. Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease.

39. Project SIGNAL: A Dashboard for Supporting Community Confidence in Making Data-Driven Decisions.

40. A Fast 3D Range-Modulator Delivery Approach: Validation of the FLUKA Model on a Varian ProBeam System Including a Robustness Analysis.

41. Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.

42. Patients presenting to the ED with nonfatal drug overdose: Self-reported history of overdose and naloxone use.

43. Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1ΔCT/LDLR KO mouse.

44. 3D Reconstruction and Virtual Reality Is an Acceptable and Feasible Method for Addressing Body Image in Bariatric Metabolic Surgery.

45. Validation of putative biomarkers of furan exposure through quantitative analysis of furan metabolites in urine of F344 rats exposed to stable isotope labeled furan.

46. Adherence to diabetes quality indicators in primary care and all-cause mortality: A nationwide population-based historical cohort study.

47. Performance, carcass quality and meat quality of the endangered German Angler Saddleback pig.

48. Plasmalogen, a glycerophospholipid crucial for Streptococcus mutans acid tolerance and colonization.

49. Stratification of Fusobacterium nucleatum by local health status in the oral cavity defines its subspecies disease association.

50. PROVIDENT: Development and Validation of a Machine Learning Model to Predict Neighborhood-level Overdose Risk in Rhode Island.

Catalog

Books, media, physical & digital resources